Product image of Letybo (Botulinum Toxin Type A) supplied by GNH India

Letybo

Active Ingredient:
Botulinum Toxin Type A
Origin:
EU

Letybo (Botulinum Toxin Type A)

Botulinum toxin type A, the active ingredient in Letybo, is a Botulinum toxin presented as a sterile injectable for intramuscular use. It temporarily relaxes targeted muscles and is used in therapeutic and aesthetic indications by blocking acetylcholine release at the neuromuscular junction, leading to temporary paralysis. The effect lasts several months, allowing repeat treatments as clinically indicated.

GNH India supplies Letybo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Croma Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Botulinum toxin type A is employed in several neuromuscular and glandular disorders where temporary muscle relaxation or reduced secretion is desired.

  • Cervical dystonia: reduces abnormal neck muscle contractions and associated pain.
  • Chronic migraine: decreases frequency of migraine attacks when injected in specific head muscles.
  • Upper limb spasticity: improves range of motion by relaxing overactive forearm muscles.
  • Hyperhidrosis: diminishes excessive sweating by inhibiting sweat gland activity.
  • Glabellar lines: smooths frown lines for cosmetic improvement.

How It Works

  • Botulinum toxin type A acts by cleaving SNAP‑25, a protein essential for the fusion of acetylcholine‑containing vesicles with the presynaptic membrane at the neuromuscular junction. This enzymatic action prevents acetylcholine release, thereby blocking neuromuscular transmission and causing a localized, reversible paralysis of the targeted muscle or gland. The effect is dose‑dependent and typically begins within days, lasting up to three months.

Side Effects

Botulinum toxin type A may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Injection site pain: mild discomfort at the injection site.
  • Bruising: small hematoma around the needle entry point.
  • Headache: transient headache following treatment.
  • Flu‑like symptoms: mild fever or malaise.
  • Localized muscle weakness: temporary reduction in strength near the injection area.

Serious or Rare Side Effects

  • Dysphagia: difficulty swallowing when neck muscles are affected.
  • Respiratory compromise: breathing difficulties if toxin spreads to respiratory muscles.
  • Allergic reactions: rash, itching, or anaphylaxis.
  • Systemic spread of toxin effect: generalized weakness or botulism‑like syndrome.
  • Vision changes: double vision or blurred sight.

Precautions & Warnings

When using Botulinum toxin type A, several precautions should be observed to ensure patient safety.

  • Pregnancy: safety not established; avoid unless clearly needed.
  • Breastfeeding: unknown safety; exercise caution.
  • Neuromuscular disorders: may exacerbate conditions such as myasthenia gravis.
  • Concurrent aminoglycoside antibiotics: increased risk of enhanced neuromuscular blockade.
  • Allergy to botulinum toxin: contraindicated in patients with known hypersensitivity.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Botulinum toxin type A can interact with other medications, affecting its safety and efficacy.

Major Interactions (Avoid)

  • Aminoglycoside antibiotics: may potentiate neuromuscular blockade.
  • Other botulinum toxin products: cumulative effect can increase toxicity.
  • Neuromuscular blocking agents: heightened risk of profound paralysis.

Moderate Interactions (Monitor Closely)

  • Anticholinergic agents: may influence muscle tone and response.
  • Calcium channel blockers: possible increase in muscle weakness.
  • Muscle relaxants: additive effect on muscle relaxation.

Frequently Asked Questions

Letybo contains botulinum toxin type A and is used to provide temporary muscle relaxation in conditions such as cervical dystonia, upper‑limb spasticity, chronic migraine, and hyperhidrosis, as well as for cosmetic reduction of glabellar lines. The treatment is administered by a qualified healthcare professional through intramuscular injection.

Botulinum toxin type A works by cleaving the SNAP‑25 protein at the neuromuscular junction, which blocks the release of acetylcholine from nerve endings. This inhibition prevents muscle contraction, resulting in a localized and reversible paralysis of the targeted muscle or gland for several months.

The dose of Letybo is individualized and set by the prescribing clinician based on the specific indication, treatment area, and patient characteristics. No standard dosing information is provided here; the healthcare provider determines the appropriate amount for each case.

Safety of Letybo in pregnancy and breastfeeding has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order Letybo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Letybo is a botulinum toxin type A formulation, similar in mechanism to other type‑A products such as onabotulinumtoxinA and incobotulinumtoxinA. Differences may exist in formulation, potency units, and approved indications, but all act by inhibiting acetylcholine release to achieve temporary muscle relaxation.

Letybo should be stored at 2‑8 °C (refrigerated). Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the product. Follow any additional handling instructions provided by the manufacturer to maintain product integrity.

Letybo is administered by a qualified healthcare professional as an intramuscular injection. The injection site, dose, and number of injection points are determined by the treating clinician according to the specific therapeutic indication.

Serious risks include dysphagia (difficulty swallowing), respiratory compromise due to spread of toxin to respiratory muscles, systemic botulism‑like syndrome, and severe allergic reactions such as anaphylaxis. Patients should be monitored closely for these events, especially after the first treatment.

Letybo should not be used in individuals with known hypersensitivity to botulinum toxin type A or any of its excipients, in patients with active infections at the proposed injection site, or in those with certain neuromuscular disorders such as myasthenia gravis where the drug may exacerbate weakness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Botulinum Toxin Type A

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT